Genetics and prevention of pancreatic cancer (Q35641985)

9 August 2017

1 reference

title

Genetics and prevention of pancreatic cancer (English)

1 reference

9 August 2017

1 reference

Dale Vimalachandran

1

1 reference

9 August 2017

Paula Ghaneh

series ordinal

2

1 reference

9 August 2017

Eithne Costello

series ordinal

3

1 reference

9 August 2017

John P Neoptolemos

series ordinal

4

1 reference

9 August 2017

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

11

1 reference

9 August 2017

6-14

1 reference

9 August 2017

1

1 reference

9 August 2017

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Resection for pancreatic cancer in the new millennium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Review article: chemotherapy for pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Mortality in relation to cigarette and pipe smoking: 16 years' observation of 25,000 Swedish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Dietary meat, dairy products, fat, and cholesterol and pancreatic cancer risk in a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

The E2F transcription factor is a cellular target for the RB protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Mutation and cancer: statistical study of retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Genetic basis of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Association of p53 gene mutations with short survival in pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Role of the INK4a locus in tumor suppression and cell mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

The INK4a/ARF network in tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Regulation of Smad activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

The null oncogene hypothesis and protection from cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Wildtype Kras2 can inhibit lung carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Genomic instability--the engine of tumorigenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Telomere shortening and tumor formation by mouse cells lacking telomerase RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Genetic progression in the pancreatic ducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Cancer-susceptibility genes. Gatekeepers and caretakers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for multistep carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Familial pancreatic adenocarcinoma in three generations. A case report and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Highlight: BRCA1 and BRCA2 proteins in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Inherited predisposition to pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Risk of pancreatic ductal adenocarcinoma in chronic pancreatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Very high risk of cancer in familial Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

A serine/threonine kinase gene defective in Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Cancer surveillance of patients from familial pancreatic cancer kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Chronic pancreatitis: diagnosis, classification, and new genetic developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Genetic testing for hereditary pancreatitis: guidelines for indications, counselling, consent and privacy issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Molecular diagnosis of pancreas carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Methylation status of p14ARF and p16INK4a as detected in pancreatic secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Genetic diagnosis of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Expression profiling of microdissected pancreatic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Pathology of incipient pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100102

10.1177/107327480401100102

21 January 2018

Identifiers

DOI

0 references

1 reference